SCHEMBL6235591

SCHEMBL6235591

CCN(CC)Cc1c[c]ccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.47
KDM4E B2RXH2 1/20 0.40
CNR2 P34972 1/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 1/20 0.39
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD1 P21728 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
ADRA1A P35348 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37
SLC6A3 Q01959 1/20 0.37
KCNH2 Q12809 1/20 0.37
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667357 0.89 HRH3 (0.43) HRH3KDM4ETSHRCHRM2HTR1A
SCHEMBL6637302 0.86 KCNH2 (0.44) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL6635619 0.84 CA12 (0.35) HRH3KDM4ECNR2TSHRMAPK1
SCHEMBL7140660 0.82 CHRNB2 (0.50) KDM4ETSHRMAOBCYP1A2CYP2D6
SCHEMBL6634540 0.82 MAPT (0.50) HRH3CHRM2HTR1AADRA2ACHRM1
SCHEMBL6234599 0.81 DRD3 (0.43) HRH3CHRM2HTR1AADRA2ACHRM1
SCHEMBL6638680 0.80 KCNH2 (0.45) HRH3OPRM1DRD3KCNH2BCHE
SCHEMBL6637319 0.79 BCHE (0.35) HRH3KDM4ETSHRADRA2ASLC6A2
SCHEMBL1041217 0.79 TSHR (0.54) HRH3TSHRSLC6A2SLC6A4ADRA1A
SCHEMBL6640076 0.79 KCNH2 (0.47) OPRM1DRD3KCNH2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165557-B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORP (US) 2004-09-29 EP claimed
US-6627624-B1 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome, NEUROGEN CORPORATION 2003-09-30 US claimed
EP-0836613-B1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS METABASIS THERAPEUTICS INC (US) 2005-05-25 EP disclosed
EP-1165557-B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS NEUROGEN CORP (US) 2004-09-29 EP disclosed
US-6627624-B1 Agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors, and are therefore useful in the diagnosis and treatment of anxiety, Down Syndrome, NEUROGEN CORPORATION 2003-09-30 US disclosed
US-5795977-A Water soluble adenosine kinase inhibitors METABASIS THERAPEUTICS, INC. (US) 1998-08-18 US disclosed
EP-0836613-A1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1998-04-22 EP disclosed
US-5726302-A SUBSTITUTED 4-AMINO PYRROLO(2,3-D) PYRIMIDINE AND PYRAZOLO(3,4-D) PYRIMIDINE NUCLEOSIDE ANALOGS GENSIA INC. (US) 1998-03-10 US disclosed
US-5654302-A Prodrug esters of phenolic 2-piperidino-1-alkanols PFIZER INC. (US) 1997-08-05 US disclosed
US-5594007-A Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols PFIZER INC. (US) 1997-01-14 US disclosed
WO-1996040707-A1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS GENSIA SICOR (US) 1996-12-19 WO disclosed
US-5455250-A Prodrug esters of phenolic 2-piperidino-1-alkanols PFIZER INC. (US) 1995-10-03 US disclosed
EP-0584192-A1 PRODRUG ESTERS OF PHENOLIC 2-PIPERIDINO-1-ALKANOLS PFIZER INC. (US) 1994-03-02 EP disclosed
WO-1992018502-A1 PRODRUG ESTERS OF PHENOLIC 2-PIPERIDINO-1-ALKANOLS PFIZER INC. (US) 1992-10-29 WO disclosed